Patent · US Active

Sulfonamide derivatives having selective Nox inhibiting activity

US12202790B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

GLUCOX BIOTECH AB · SE

Inventors

Per Wikström · Uppsala, SE
Erik Walum

Key dates

Filing date	May 9, 2019
Grant date	Jan 21, 2025
Priority date	—
Expiry date	Nov 16, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase 4 or 2 (Nox4 or Nox2) activity. A pharmaceutical composition comprising the compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.